Some researchers have found that AT1-receptor activation could induce superoxide radical release via the NAPDH oxidase pathway, increasing oxidative stress, and thus leading to endothelial dysfunction [29, 30]. The gene discussed is FMO5; the disease is endothelial dysfunction.